→Appendix 1: mianserin
PDF page 411
Agranulocytosis. arthritis. bone marrow
disorders. breast abnormalities. dizziness.
granulocytopenia. gynaecomastia. hepatic disorders.
hyperhidrosis. hyponatraemia. joint disorders. lactation
in absence of pregnancy. leucopenia. mood altered.
neuromuscular irritability. oedema. paranoid delusions.
postural hypotension. psychosis. rash. seizure. sexual
dysfunction. suicidal tendencies. tremor. withdrawal
syndrome
SIDE-EFFECTS, FURTHER INFORMATION The risk of side-
effects is reduced by titrating slowly to the minimum
effective dose (every 2–3 days). Consider using a lower
starting dose in elderly patients.
Overdose The tricyclic-related antidepressant drugs may
be associated with a lower risk of cardiotoxicity in
overdosage.
Tricyclic and related antidepressants cause dry mouth,
coma of varying degree, hypotension, hypothermia,
hyperreflexia, extensor plantar responses, convulsions,
respiratory failure, cardiac conduction defects, and
arrhythmias. Dilated pupils and urinary retention also
occur. For details on the management of poisoning see
Tricyclic and related antidepressants under Emergency
treatment of poisoning p. 1430.
PDF page 411
Avoid.
PDF page 411
The amount secreted into breast milk is
too small to be harmful.
Nervous system
PDF page 411
Manufacturer advises caution; avoid
in severe impairment.
PDF page 411
Dose adjustments Caution in renal impairment.
PDF page 411
A full blood count is
recommended every 4 weeks during the first 3 months of
treatment; clinical monitoring should continue
subsequently and treatment should be stopped and a full
blood count obtained if fever, sore throat, stomatitis, or
other signs of infection develop.
PDF page 411